TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)

NCT05718856 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

166

Enrollment

OTHER

Sponsor class

Conditions

Primary Immune Thrombocytopenia (ITP)

Interventions

DRUG: TPO-RAs
DRUG: TPO-RAs combining anti-CD 20 monoclonal antibody

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]